(2'-5')Oligoadenylate synthetase (2-SA synthetase), which catalyzes the formation of 2-5A from ATP in the presence of double-stranded RNA, is an enzyme induced in the cell by the addition of interferons (5) . The 2-5A system, which is composed of 2-5A synthetase, 2'-5'-phosphodiesterase and 2-5A-dependent RNase, is thought to play an important role in the antiviral function of interferon (7) . The induction of 2-5A synthetase was also shown in tissues of animals infected with viruses (6, 16) . Thus, the increase in 2-5A synthetase is one of the most sensitive biochemical markers of cells in response to interferon or viral infections. In fact, high levels of the synthetase activity were detected in peripheral lymphocytes from patients injected with interferon (8, 13) and from patients suffering from various virus infections (1, 2, 3, 14, 17) . Recently, the assay of 2-5A synthetase was suggested to be a useful prognostic indicator for acquired immunodeficiency syndrome (9, 10) . However, the isolation of lymphocytes from peripheral blood is so complicated that in daily clinical work this assay method has not been used widely. If we could detect 2-SA synthetase activity in serum instead of in lymphocytes, the application of this enzyme assay in diagnosis would become very convenient. Therefore, we tried to detect 2-5A synthetase activity in serum obtained from children suffering from several infectious diseases by a sensitive radioimmunoassay method.
In this study, we examined 63 serum samples from healthy adult individuals and 101 samples from the following 70 children: 17 patients with viral diseases, including 7 with respiratory syncytial virus infection, 6 with rotavirus infection, 2 with measles, and 1 each with varicella and herpangina; 13 patients with bacterial infections, including 5 with scarlet fever, 2 with pertussis, 2 with appendicitis, and 1 each with bacterial meningitis, purulent lymphoadenitis, omphalitis, and furuncle; 11 pmol/h per dl of serum (Fig. 1) . In 31 serum samples from 29 children with noninfectious disease, the synthetase level and standard deviation was 70 ± 42 pmol, which was slightly higher than that in serum from adult individuals (P < 0.001). On the other hand, the mean level and standard deviation of 2-5A synthetase activity in 21 serum samples from 15 patients in the acute phase of viral diseases was 456 + 250 pmol/h per dl of serum, and the range was from 86 to >810 pmol (Fig. 1) . In patients suffering from respiratory syncytial virus or rotavirus infections, the levels of serum 2-SA synthetase were highest on day 3 or 4 after onset of the illness, followed by a decrease during the convalescent phase of disease ( Table 1 ). The titers of complement fixation antibody against respiratory syncytial virus were elevated when 2-5A synthetase levels declined (Table 1) . These results clearly indicate that the levels of serum 2-SA synthetase from patients in the acute phase of viral infections were 2-5A(p mol/dl) enhanced significantly, in contrast with those of serum from healthy adults or patients with noninfectious disease (P < 0.001). All 10 serum samples from nine patients with mycoplasmal infections which were diagnosed as primary atypical pneumonia showed increased levels of 2-5A synthetase in their acute phase (308 ± 118 pmol) (Fig. 1) . However, the enzyme activities in serum decreased during recovery from the disease, when the increased complement fixation antibody titer was observed (Table 2 ). In 13 patients with bacterial infections, the enzyme level in serum was 112 ± 88 pmol, which was not as high as that in patients with viral infections (P < 0.001), except for one patient suffering from scarlet fever (344 pmol) (Fig. 1) . Mycoplasma, some bacteria, and bacterial endotoxin are known to be interferon inducers (18) , but the results described above indicate that they are not as good an inducer of 2-5A synthetase as viruses are. It was also shown that the injection of interferon made the level of serum 2-5A synthetase increase (data not shown).
It has been reported that the activity of 2-5A synthetase was significantly increased in peripheral blood mononuclear leukocytes from patients with several idiopathic inflammatory diseases, such as systemic lupus erythematosus, sarcoidosis, and Vogt-Koyanagi-Harada disease (4). However, there was no relationship between the levels of 2-5A synthetase and those of C-reactive protein, which is an indicator of inflammatory diseases (Fig. 2) . Even in some bacterial infections in which high levels of C-reactive protein were observed, the activities of 2-5A synthetase remained at low levels.Thus, the elevation of 2-5A synthetase levels in serum reported here was not the result of a nonspecific inflammatory response. Although the reason why 2-5A synthetase appears in serum after viral infection or interferon injection is not clear, it may be due to the degeneration of lymphocytes during their life cycle, since this enzyme may not be a secreted one.
As shown here, for the measurement of 2-5A synthetase in clinical use, serum could be substituted for lymphocytes; serum is very convenient for this purpose. For example, lymphocytes should be isolated immediately after venipuncture by density gradient centrifugation using at least 2 ml of blood, whereas the isolation of serum is a simple procedure and the volume of serum needed for an assay is as small as 50 RI. 
